The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and β-amyloid pathologies
Abstract
Investigation of the integrity of the ryanodine receptor in Alzheimer's disease is important because it plays a critical role in the regulation of calcium release from the endoplasmic reticulum in brain, impairment of which is believed to contribute to the pathogenesis of Alzheimer's disease. The present study compared ryanodine receptor levels and their functional modulation in particulate fractions from control and Alzheimer's disease temporal cortex, occipital cortex and putamen. Relationships between ryanodine receptor changes and the progression of Alzheimer's disease pathology were determined by examining autoradiographic [3H]ryanodine binding in entorhinal cortex/anterior hippocampus sections from 22 cases that had been staged for neurofibrillary changes and beta-amyloid deposition. A significant (P < 0.02) 40% decrease in the Bmax for [3H]ryanodine binding and significantly higher IC50 values for both magnesium and Ruthenium Red inhibition of [3H]ryanodine binding were detected in Alzheimer's disease temporal cortex particulate fractions compared to controls. Immunoblot analyses showed Type 2 ryanodine receptor holoprotein levels to be decreased by 20% (P < 0.05) in these Alzheimer's disease cases compared to controls. No significant differences were detected in [3H]ryanodine binding comparing control and Alzheimer's disease occipital cortex or putamen samples. The autoradiography study detected increased [3H]ryanodine binding in the subiculum, CA2 and CA1 regions in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The neuronal ryanodine receptor (Ryr2) is overactivated in AD, leading to enhanced receptor-operated calcium entry and decreased buffering capacity.
“The neuronal ryanodine receptor (Ryr2) is overactivated in AD, leading to enhanced receptor-operated calcium entry and decreased buffering capacity [18, 21].”
From Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer’s disease mouse model (2025) · cites this paper as [18]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Evolution of the neuropathology of Alzheimer's disease
Braak, H., & Braak, E. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05866.x · Cited by 710
Flagged first, then by citations
Research works printed but not linked: 80
- Alcazar, 1997, Calcium mobilization by ryanodine promotes the phosphorylation of initiation factor 2α subunit and inhibits protein synthesis in cultured neurons, J. Neurochem., 69, 1703, 10.1046/j.1471-4159.1997.69041703.x · DOI
- Arendt, 1995, Increased expression and subcellular translocation of the mitogen-activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease, Neuroscience, 68, 5, 10.1016/0306-4522(95)00146-A · DOI
- Berridge, 1997, Elementary and global aspects of calcium signalling, J. exp. Biol., 200, 315, 10.1242/jeb.200.2.315 · DOI
- Brandt, 1992, Mapping of the calpain proteolysis products of the junctional foot protein of the skeletal muscle triad junction, J. Membr. Biol., 127, 35, 10.1007/BF00232756 · DOI
- Breuer, 1992, Fast axonal transport is modulated by altering trans-axolemmal calcium flux, Cell Calcium, 13, 249, 10.1016/0143-4160(92)90013-I · DOI
- Brillantes, 1994, Stabilisation of calcium release channel (ryanodine receptor) function by FK506-binding protein, Cell, 77, 513, 10.1016/0092-8674(94)90214-3 · DOI
- Brooks, 1992, Bound and determined: a computer program for making buffers of defined ion concentrations, Analyt. Biochem., 201, 119, 10.1016/0003-2697(92)90183-8 · DOI
- Brun A. An overview of light and microscopic changes. (1983) In Alzheimer's Disease: The Standard Reference. (ed. Reisberg B.), pp. 37–47, Free Press, New York.
- Cameron, 1995, Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux, Cell, 83, 463, 10.1016/0092-8674(95)90124-8 · DOI
- Cavallaro, 1997, Late memory-related genes in the hippocampus revealed by RNA fingerprinting, Proc. natn. Acad. Sci. U.S.A., 94, 9669, 10.1073/pnas.94.18.9669 · DOI
- Chavis, 1996, Functional coupling between ryanodine receptors and L-type calcium channels in neurons, Nature, 382, 719, 10.1038/382719a0 · DOI
- Chu, 1990, Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel, Molec. Pharmac., 37, 735, 10.1016/S0026-895X(25)10918-8 · DOI
- Cook, 1996, Expression and analysis of presenilin 1 in a human neuronal system: localisation in cell bodies and dendrites, Proc. natn. Acad. Sci. U.S.A., 93, 9223, 10.1073/pnas.93.17.9223 · DOI
- Cook, 1997, Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells, Nature Med., 3, 1021, 10.1038/nm0997-1021 · DOI
- Coronado, 1994, Structure and function of ryanodine receptors, Am. J. Physiol., 266, C1485, 10.1152/ajpcell.1994.266.6.C1485 · DOI
- Cowburn, 1992, Adenylyl cyclase activity in postmortem human brain: evidence for altered G protein mediation in Alzheimer's disease, J. Neurochem., 58, 1409, 10.1111/j.1471-4159.1992.tb11357.x · DOI
- Cowburn, 1996, Neurotransmitter receptor/G protein mediated signal transduction in Alzheimer's disease brain, Neurodegeneration, 5, 483, 10.1006/neur.1996.0067 · DOI
- Fiorillo, 1998, Glutamate mediates an inhibitory post-synaptic potential in dopamine neurons, Nature, 394, 78, 10.1038/27919 · DOI
- Flynn, 1995, Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease, J. Neurochem., 64, 1888, 10.1046/j.1471-4159.1995.64041888.x · DOI
- Furuichi, 1994, Multiple types of ryanodine receptor/Ca2+ release channels are differentially expressed in rabbit brain, J. Neurosci., 14, 4794, 10.1523/JNEUROSCI.14-08-04794.1994 · DOI
- Garlind, 1995, Diminished [3H]inositol (1,4,5)P3 but not [3H]inositol (1,3,4,5)P4 binding in Alzheimer's disease brain, Brain Res., 681, 160, 10.1016/0006-8993(95)00311-D · DOI
- Geary, 1985, Quantitative film autoradiography for tritium methodological considerations, Brain Res., 337, 99, 10.1016/0006-8993(85)91613-0 · DOI
- Ghosh, 1995, Calcium signalling in neurons: molecular mechanisms and cellular consequences, Science, 268, 239, 10.1126/science.7716515 · DOI
- Giannini, 1995, The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues, J. Cell Biol., 128, 893, 10.1083/jcb.128.5.893 · DOI
- Gong, 1994, Alzheimer's disease abnormally phosphorylated τ is dephosphorylated by protein phosphatase-2B (calcineurin), J. Neurochem., 62, 803, 10.1046/j.1471-4159.1994.62020803.x · DOI
- Gong, 1995, Phosphatase activity towards abnormally phosphorylayed τ: decrease in Alzheimer disease brain, J. Neurochem., 65, 732, 10.1046/j.1471-4159.1995.65020732.x · DOI
- Greenwood, 1995, Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease, Neuroscience, 69, 125, 10.1016/0306-4522(95)00220-D · DOI
- Grynspan, 1997, Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease, Brain Res., 763, 145, 10.1016/S0006-8993(97)00384-3 · DOI
- Guo, 1996, Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitises PC-12 cells to death induced by amyloid β-peptide, NeuroReport, 8, 379, 10.1097/00001756-199612200-00074 · DOI
- Guo, 1997, Alzheimer's presenilin mutation sensitises neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals, J. Neurosci., 17, 4212, 10.1523/JNEUROSCI.17-11-04212.1997 · DOI
- Hain, 1995, Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle, J. biol. Chem., 270, 2047, 10.1074/jbc.270.5.2074 · DOI
- Hardy, 1997, Amyloid, the presenilins and Alzheimer's disease, Trends Neurosci., 20, 154, 10.1016/S0166-2236(96)01030-2 · DOI · Paper page
- Hartmann, 1998, Distinct sites of intracellular production for Alzheimer's Aβ40/42 amyloid peptides, Nature Med., 3, 1016, 10.1038/nm0997-1016 · DOI
- Hutton, 1998, The presenilins and Alzheimer's disease, Human molec. Genet., 6, 1639, 10.1093/hmg/6.10.1639 · DOI
- Johnson, 1996, Tau protein in normal and Alzheimer's disease brain, Alzheimer's Dis. Rev., 1, 38
- Jolly-Tornetta, 1998, Regulation of amyloid precursor protein secretion by glutamate receptors in human Ntera 2 neurons (NT2N), J. biol. Chem, 273, 14015, 10.1074/jbc.273.22.14015 · DOI
- Jope, 1997, Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain, Neurobiol. Aging, 18, 111, 10.1016/S0197-4580(96)00205-9 · DOI
- Kawai, 1989, Effects of ryanodine on spike after-hyperpolarisation in sympathetic neurones of the rat superior cervical ganglion, Pflügers Arch. Eur. J. Physiol., 413, 470, 10.1007/BF00594175 · DOI
- Kovacs, 1996, Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells, Nature Med., 2, 224, 10.1038/nm0296-224 · DOI
- Kurumatani, 1998, Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology, Brain Res., 796, 209, 10.1016/S0006-8993(98)00347-3 · DOI
- Ladner, 1995, Regional alterations in M1 muscarinic receptor-G protein coupling in Alzheimer's disease, J. Neuropath. exp. Neurol., 54, 783, 10.1097/00005072-199511000-00005 · DOI
- Laemmli, 1970, Cleavage of structural proteins during assembly of the macrophage T4, Nature, 227, 680, 10.1038/227680a0 · DOI · Paper page
- Lah, 1997, Light and electron microscopic localization of presenilin-1 in primate brain, J. Neurosci., 17, 1971, 10.1523/JNEUROSCI.17-06-01971.1997 · DOI · Paper page
- Lokuta, 1997, Modulation of cardiac ryanodine receptors by sorcin, J. biol. Chem., 272, 25333, 10.1074/jbc.272.40.25333 · DOI
- Makrill, 1997, Differential expression and regulation of ryanodine receptor and myo-inositol 1,4,5-trisphosphate receptor calcium release channels in mammalian tissues and cell lines, Biochem. J., 327, 251, 10.1042/bj3270251 · DOI
- Markwell, 1978, Modification of the standard Lowry procedure to simplify protein determination in membranes and lipoprotein samples, Analyt. Biochem., 87, 206, 10.1016/0003-2697(78)90586-9 · DOI
- Mattson, 1991, Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cerebral cortical neurones, Molec. chem. Neuropath., 15, 117, 10.1007/BF03159951 · DOI
- Mattson, 1998, Presenilins, the endoplasmic reticulum and neuronal apoptosis in Alzheimer's disease, J. Neurochem., 70, 1, 10.1046/j.1471-4159.1998.70010001.x · DOI
- McKhann, 1984, Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
- McPherson, 1993, Characterization of the major brain isoform of the ryanodine receptor/Ca2+ release channel, J. biol. Chem., 268, 19785, 10.1016/S0021-9258(19)36582-2 · DOI
- Meissner, 1994, Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors, A. Rev. Physiol., 56, 485, 10.1146/annurev.ph.56.030194.002413 · DOI
- Meyers, 1998, Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels, J. biol. Chem., 273, 18930, 10.1074/jbc.273.30.18930 · DOI
- Michalak, 1988, Ryanodine binding to sarcoplasmic reticulum membrane; comparison between cardiac and skeletal muscle, Biochim. biophys. Acta., 939, 587, 10.1016/0005-2736(88)90106-X · DOI
- Mirra, 1991, The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment for Alzheimer's disease, Neurology, 41, 479, 10.1212/WNL.41.4.479 · DOI · Paper page
- Munson, 1980, LIGAND: a versatile computerized approach for characterization of ligand-binding systems, Analyt. Biochem., 107, 220, 10.1016/0003-2697(80)90515-1 · DOI
- Nishimura, 1990, Ryanodine facilitates calcium dependent release of transmitter at mouse neuromuscular junction, Br. J. Pharmac., 100, 114, 10.1111/j.1476-5381.1990.tb12061.x · DOI
- Nixon, 1994, Calcium activated neutral proteinase (calpain) system in aging and Alzheimer's disease, Ann. N.Y. Acad. Sci., 747, 77, 10.1111/j.1749-6632.1994.tb44402.x · DOI
- Ohm, 1989, A competition between silver-stain and immunocytochemistry, J. neural. Transm., 1, 111, 10.1007/BF02312273 · DOI
- Ohm, 1995, Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes, Neuroscience, 64, 209, 10.1016/0306-4522(95)90397-P · DOI
- Ohm, 1997, Decrease in adenylate cyclase activity antecedes neurofibrillary tangle formation, Neurobiol. Aging, 18, 275, 10.1016/S0197-4580(97)80307-7 · DOI
- O'Neill, 1991, Coupling of human brain cerebral cortical α2-adrenoreceptors to GTP-binding proteins in Alzheimer's disease, Brain Res., 563, 39, 10.1016/0006-8993(91)91512-Y · DOI
- O'Neill, 1994, Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain, Brain Res., 636, 193, 10.1016/0006-8993(94)91017-0 · DOI
- Padua, 1994, Ionic strength of calcium, adenine nucleotide, magnesium and caffeine actions on ryanodine receptors in rat brain, J. Neurochem., 62, 2340, 10.1046/j.1471-4159.1994.62062340.x · DOI
- Paschen, 1996, Depletion of neuronal endoplasmic reticulum calcium stores by thapsigargin: effect on protein synthesis, J. Neurochem., 67, 1735, 10.1046/j.1471-4159.1996.67041735.x · DOI
- Pearson, 1989, The neuroanatomy of Alzheimer's disease, Rev. Neurosci., 2, 101, 10.1515/REVNEURO.1989.2.2.101 · DOI
- Querfurth, 1997, Caffeine stimulates amyloid β-peptide release from β-amyloid precursor protein-transfected HEK293 cells, J. Neurochem., 69, 1580, 10.1046/j.1471-4159.1997.69041580.x · DOI
- Rardon, 1990, Digestion of cardiac and skeletal muscle junctional sarcoplasmic reticulum vesicles with calpain II. Effects on the Ca2+ release channel, Circulation Res., 67, 84, 10.1161/01.RES.67.1.84 · DOI
- Reisberg, 1982, The global deterioration scale (GDS): an instrument for the assessment of the primary degenerative dementia, Am. J. Psychiat., 139, 1136, 10.1176/ajp.139.9.1136 · DOI
- Saito, 1993, Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration, Proc. natn. Acad. Sci. U.S.A., 90, 2628, 10.1073/pnas.90.7.2628 · DOI
- Sharp, 1993, Differential immunohistochemical localization of inositol 1,4,5-trisphosphate- and ryanodine-sensitive Ca2+ release channels in rat brain, J. Neurosci., 13, 3051, 10.1523/JNEUROSCI.13-07-03051.1993 · DOI
- Shimohama, 1998, Phospholipase C isoenzymes in the human brain and their changes in Alzheimer's disease, Neuroscience, 82, 999, 10.1016/S0306-4522(97)00342-4 · DOI
- Shoshan-Barmatz, 1994, Endogenous Ca2+ dependent cysteine-protease cleaves specifically the ryanodine receptor/Ca2+ release channel in skeletal muscle, J. Membr. Biol., 142, 281, 10.1007/BF00233435 · DOI
- Simpson, 1995, Neuronal calcium stores: activation and function, Trends Neurosci., 18, 299, 10.1016/0166-2236(95)93919-O · DOI
- Simpson, 1996, Agonist evoked Ca2+ mobilization from stores expressing inositol 1,4,5-trisphosphate receptors and ryanodine receptors in cerebellar granule neurones, J. Neurochem., 67, 364, 10.1046/j.1471-4159.1996.67010364.x · DOI
- Smith, 1993, Characterisation and distribution of inositol polyphosphate and ryanodine receptors in the rat brain, J. Neurochem., 60, 1605, 10.1111/j.1471-4159.1993.tb13382.x · DOI
- Stein, 1992, High affinity [3H]ryanodine binding sites in postmortem human brain: regional distribution and effects of calcium, magnesium and caffeine, Brain Res., 58, 5349
- Timerman, 1996, Characterisation of an exchange reaction between soluble FKBP-12 and the FKBP ryanodine receptor complex, J. biol. Chem., 270, 2451
- Verkhratsky, 1996, Calcium-induced calcium release in neurones, Cell Calcium, 19, 1, 10.1016/S0143-4160(96)90009-3 · DOI
- Walter, 1996, The Alzheimer's disease associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum, Molec. Med., 2, 673, 10.1007/BF03401652 · DOI
- Younkin, 1995, Evidence that A beta 42 is the real culprit in Alzheimer's disease, Ann. Neurol., 37, 287, 10.1002/ana.410370303 · DOI
Cited by
Sorted by citations
Molecular Mechanisms and Clinical Implications of Reversible Protein S -Glutathionylation
Mieyal, J. J., Gallogly, M. M., Qanungo, S., Sabens, E. A., & Shelton, M. D. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2089 · Cited by 523
Griffin, R. J., Moloney, A., Kelliher, M., Johnston, J. A., Ravid, R., Dockery, P., O'Connor, R., & O'Neill, C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02949.x · Cited by 459
Self-citationIncreased intraneuronal resting [Ca2+] in adult Alzheimer’s disease mice
Lopez, J. R., Lyckman, A., Oddo, S., LaFerla, F. M., Querfurth, H. W., & Shtifman, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05135.x · Cited by 162
The aged rhesus macaque manifests Braak stage III/IV Alzheimer's‐like pathology
Paspalas, C. D., Carlyle, B. C., Leslie, S., Preuss, T. M., Crimins, J. L., Huttner, A. J., van Dyck, C. H., Rosene, D. L., Nairn, A. C., & Arnsten, A. F. T. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.11.005 · Cited by 140
Critical review: involvement of endoplasmic reticulum stress in the aetiology of Alzheimer's disease
Hashimoto, S., & Saido, T. C. (2018) · Open Biology · doi:10.1098/rsob.180024 · Cited by 129
Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
McDaid, J., Mustaly-Kalimi, S., & Stutzmann, G. E. (2020) · Cells · doi:10.3390/cells9122655 · Cited by 73
Webber, E. K., Fivaz, M., Stutzmann, G. E., & Griffioen, G. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13065 · Cited by 50
Mechanisms of Neuron Loss in Alzheimer’s Disease
Mukhin, V. N., Pavlov, K. I., & Klimenko, V. M. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0427-x · Cited by 27
Ramonet, D., Daerr, A., & Hallbeck, M. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02096-8 · Cited by 7
Metadata
- Authors
- Kelliher, M., Fastbom, J., Cowburn, R. F., Bonkale, W., Ohm, T. G., Ravid, R., Sorrentino, V., & O'Neill, C.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1999-05
- Volume
- 92
- Issue
- 2
- Pages
- 499-513
- ISSN
- 0306-4522
- Cited by
- 129
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review